RSS   Newsletter   Contact   Advertise with us
Post Online Media

MyoKardia appoints David Meeker to board

MyoKardiaMyoKardia, a clinical stage biopharmaceutical company, announced the appointment of David Meeker to the company’s board of directors.

Dr. Meeker is executive vice president and head of Sanofi Genzyme, the specialty care global business unit of Sanofi that focuses on rare diseases, multiple sclerosis, oncology, and immunology.

Article continues below

READ MORE MyoKardia appoints June Lee as COO

As executive vice president of Sanofi, he served as a member of the executive committee.

Dr. Meeker joined Genzyme in 1994 and held positions of increasing responsibility including vice president, medical affairs, chief operating officer and ultimately president and chief executive officer.

Prior to joining Genzyme, Dr. Meeker was director of the Pulmonary Critical Care Fellowship at the Cleveland Clinic and an assistant professor of medicine at The Ohio State University.

He has authored more than 40 articles and multiple book chapters.

Dr. Meeker received his M.D. degree from the University of Vermont Medical School.

He completed the Advanced Management Program at Harvard Business School in 2000.


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy